Your session is about to expire
← Back to Search
Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
Phase 2
Waitlist Available
Led By Emily Grade, MD
Research Sponsored by Arizona Oncology Services
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Summary
Participants will be diagnosed with localized prostate or breast cancer and be scheduled to undergo external beam radiation therapy. Participants will either receive a placebo or organic germanium to be taken 5 times a day starting the day of their first radiation and continuing through the 1 month follow-up visit. Weekly Quality of life forms will be completed through the one month follow up visit and then at the 3 month follow up visit. Labs will be done prior to the start of treatment, at the end of treatment and at the one and three month follow-up visits.
Eligible Conditions
- Prostate Cancer
- Breast cancer
- External Beam Radiotherapy
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: 1Active Control1 Intervention
Organic Germanium tablets 5 times a day
Group II: 2Placebo Group1 Intervention
Placebo tablets 3 -5 times per day
Find a Location
Who is running the clinical trial?
Arizona Oncology ServicesLead Sponsor
Emily Grade, MDPrincipal InvestigatorArizona Oncology Services